Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...

Mr. Iwicki stated, “I am proud of the work we have done at KALA utilizing our MSC-S platform, and I am very excited about the potential of our lead product candidate, KPI-012 for the treatment of PCED ...

KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...

Using a series of more than 1,000 X-ray snapshots of the shapeshifting of enzymes in action, researchers at Stanford ...

MANN, the test developed at OHSU could help save lives Jared Fischer, Ph.D., left, and Jose Luis Montoya Mira, Ph.D., cancer ...

A viral trend argues that this diet is dangerous due to anti-nutrients. Is this claim grounded in science, or is it just ...

Shares of Chimerix (NASDAQ: NASDAQ: CMRX) climbed 12.5% as the company announced the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for dordaviprone, a potential ...

Furin is identified as the key enzyme responsible for cleaving the apelin precursor. Inhibiting this cleavage could serve as ...

This study identifies 47,350 enhancers active in human neurons during differentiation and links some to genes involved in ...

OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients, today ...

However, it "seeks fair compensation for Pfizer's use of a coronavirus 3CL protease inhibitor claimed in the '953 patent." There's a potential third wheel in the dispute, according to SVB ...

Then, in 1985, Abbott launched the world's first HIV antibody assay. In 1996, one of the first protease inhibitor drugs indicated in combination with other antiretroviral agents for the treatment ...